Peritoneal Effluent MicroRNA Profile for detection of Encapsulating Peritoneal Sclerosis.

[1]  Yongfei Hu,et al.  RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility , 2021, Nucleic Acids Res..

[2]  Xiaoli Chen,et al.  MiR‐17‐5p downregulation alleviates apoptosis and fibrosis in high glucose‐induced human mesangial cells through inactivation of Wnt/β‐catenin signaling by targeting KIF23 , 2021, Environmental toxicology.

[3]  C. Chou,et al.  A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients , 2021, BioMed research international.

[4]  Zhizhan Ni,et al.  Sclerosing encapsulating peritonitis as a rare cause of intestinal obstruction after the treatment of peritoneal mesothelioma: a case report and review of the literature , 2021, Translational cancer research.

[5]  P. Zhou,et al.  MiRNA-155-5p inhibits epithelium-to-mesenchymal transition (EMT) by targeting GSK-3β during radiation-induced pulmonary fibrosis. , 2020, Archives of biochemistry and biophysics.

[6]  Cheng Chen,et al.  miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6 , 2020, Oxidative medicine and cellular longevity.

[7]  J. Xia,et al.  miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology , 2020, Nucleic Acids Res..

[8]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[9]  Yingying Chen,et al.  Inhibition of miR-155-5p Exerts Anti-Fibrotic Effects in Silicotic Mice by Regulating Meprin α , 2019, Molecular therapy. Nucleic acids.

[10]  Jorng-Tzong Horng,et al.  Plasma miRNA profile is a biomarker associated with urothelial carcinoma in chronic hemodialysis patients. , 2019, American journal of physiology. Renal physiology.

[11]  Zhi-Yong Guo,et al.  HIF1A and VEGF regulate each other by competing endogenous RNA mechanism and involve in the pathogenesis of peritoneal fibrosis. , 2019, Pathology, research and practice.

[12]  Hui-Ying Wu,et al.  Overexpression of microRNA-202-3p protects against myocardial ischemia-reperfusion injury through activation of TGF-β1/Smads signaling pathway by targeting TRPM6 , 2019, Cell cycle.

[13]  N. Khandelwal,et al.  Encapsulating Peritoneal Sclerosis: The Abdominal Cocoon. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.

[14]  Shih-Chieh Lin,et al.  microRNA expression pattern as an ancillary prognostic signature for radiotherapy , 2018, Journal of Translational Medicine.

[15]  I. MacRae,et al.  Regulation of microRNA function in animals , 2018, Nature Reviews Molecular Cell Biology.

[16]  Martin P. Smith,et al.  Encapsulating peritoneal sclerosis , 2010, Radiopaedia.org.

[17]  Chiu-Ching Huang,et al.  Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS , 2018, PloS one.

[18]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[19]  Q. Qian,et al.  The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis. , 2017, Journal of the American Society of Nephrology : JASN.

[20]  David W. Johnson,et al.  Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis — Position Paper for ISPD: 2017 Update , 2017, Peritoneal Dialysis International.

[21]  Hui Luo,et al.  MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  David W. Johnson,et al.  Changes in the worldwide epidemiology of peritoneal dialysis , 2017, Nature Reviews Nephrology.

[23]  B. C. Kwan,et al.  Peritoneal dialysis effluent miR-21 and miR-589 levels correlate with longitudinal change in peritoneal transport characteristics. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[24]  R. Y. Cao,et al.  The Emerging Role of MicroRNA-155 in Cardiovascular Diseases , 2016, BioMed research international.

[25]  Deguang Yang,et al.  Role of Mir-155 in Controlling HIF-1α Level and Promoting Endothelial Cell Maturation , 2016, Scientific Reports.

[26]  D. Iliopoulos,et al.  Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  F. Schena,et al.  Role of miR-422a and kallikrein-related peptidase 4 implicated in the development of lupus nephritis. Do we work in this direction? , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  Bicheng Chen,et al.  MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis , 2015, Oncotarget.

[29]  A. Garg,et al.  Worldwide access to treatment for end-stage kidney disease: a systematic review , 2015, The Lancet.

[30]  D. Struijk,et al.  Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  M. Betjes,et al.  Lower Mortality and Inflammation from Post-Transplantation Encapsulating Peritoneal Sclerosis Compared to the Classical Form , 2013, American Journal of Nephrology.

[32]  Amit X Garg,et al.  Global trends in rates of peritoneal dialysis. , 2012, Journal of the American Society of Nephrology : JASN.

[33]  Xu Gao,et al.  MiR‐483‐5p controls angiogenesis in vitro and targets serum response factor , 2011, FEBS letters.

[34]  R. Krediet,et al.  Encapsulating peritoneal sclerosis: the state of affairs , 2011, Nature Reviews Nephrology.

[35]  Hester F. Lingsma,et al.  Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[37]  D. Struijk,et al.  EARLY DIAGNOSTIC MARKERS FOR ENCAPSULATING PERITONEAL SCLEROSIS: A CASE-CONTROL STUDY , 2010, Peritoneal Dialysis International.

[38]  R. Pecoits-Filho,et al.  Peritoneal Dialysis in the Developing World: Recommendations from a Symposium at the Ispd Meeting 2008 , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[39]  K. Simpson,et al.  Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[40]  M. Wilkie,et al.  Encapsulating Peritoneal Sclerosis: Clinical Significance and Implications , 2009, Nephron Clinical Practice.

[41]  W. Gedroyc,et al.  Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[42]  J. Jimenez-Heffernan,et al.  Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. , 2007, Journal of the American Society of Nephrology : JASN.

[43]  P. Brenchley,et al.  Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. , 2005, Kidney international.

[44]  Y. Kawaguchi,et al.  Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[46]  S. Kuriyama,et al.  Corticosteroid therapy in encapsulating peritoneal sclerosis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.